Beruflich Dokumente
Kultur Dokumente
DAFTAR PUSTAKA
19. Kim K, Lee JH, Kim JS, Min CK, Yoon SS, Shimizu K, et al. Clinical
profiles of multiple myeloma in Asia-An Asian Myeloma Network study.
Am J Hematol. 2014;89:751-6.
20. Sinuraya ES. Registrasi Kanker Rumah Sakit Kanker Dharmais tahun
1993-2010.
21. Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, et al.
Multiple myeloma: a review of the epidemiologic literature. Int J Cancer.
2007;120 Suppl 12:40-61.
22. Khan MM, Mori Mitsuru, Sakauchi Fumio, Matsuo K, Ozasa K,
Tamakoshi A. Risk factor for multiple myeloma: Evidence from the Japan
Collaborative Cohort (JACC) Study. 2006. Asian Pac J Cancer Prev.
2006;7:575-81
23. Palumbo A, Anderson K. Multiple Myeloma. N Engl J Med
2011;364:1046-60.
24. Tan D, Chng WJ, Chou T, Nawarawong SY, Hwang SY, Chim CS, et al.
Management of multiple myeloma in Asia: resource-startified guidelines.
Lancet 2013;14:571-9.
25. Bringhen S, Mateos MV, Zweegman S, Larocca A, Falcone AP, Oriol A, et
al. Age and organ damage correlate with poor survival in myeloma
patients: Meta-analysis of 1435 individual patient data from 4 randomized
trials. Haematologica 2013;98:980-7.
26. Chanan-Khan AA, Giralt S. Importance of achieving a complete response
in multiple myeloma, and the impact of novel agents. J Clin Oncol.
2010;15(28):2612-24.
27. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi
FK, et al. Improved survival in multiple myeloma and the impact of novel
therapies. Blood. 2008;5(111):2516-20.
28. Gay F, Larocca A, Wijermans P, Cavallo F, Rossi D, Schaafsma R, et al.
Complete response correlates with long-term progression-free and overall
survival in elderly myeloma treated with novel agents: analysis of 1175
patients. Blood. 2011;117:3025-31.
29. Moreau P, Attal M, Facon T. Frontline therapy of multiple myeloma.
Blood. 2015;20:3076-84.
41
30. Durie BGM, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K,
et al. International uniform response criteria for multiple myeloma.
Leukemia. 2006;20:1467-73.
31. Chang X, Zhu Y, Shi C, Stewart AK. Mechanism of immunomodulatory
drugs action in the treatment of multiple myeloma. Acta Biochim Biophys
Sin. 2014;46(3):240-7.